Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Biopharm Knowledge Publishing | Central and Core Laboratories

Central and Core Laboratories

A definitive report on the current status and future prospects of Central Clinical Pathology Laboratories, Central ECG Analysis Laboratories and Central Bio-imaging Laboratories.

Updated, October 2007

The Central and Core Laboratories market is now worth more than $1.5 billion a year and is vital to the successful development of new drugs. It is a truly global business dominated by major players.

Choosing the right Central Laboratory and handling the relationship effectively is vital to the successful management of clinical trials, as is the complex business of getting samples from the patient to the laboratory.

In a publishing breakthrough this 250 page report – updated October 2007 – gives comprehensive cover the Central Laboratories market, the major companies involved, the processes, including testing and logistics and the future challenges for the market. It is a vital resource for anyone involved in drug development, clinical trials, the central labs market and logistics.

Contents include:

> Overview of capabilities and facilities

> Role of Central Labs in clinical trials

> History of the Central Labs business

> Contract Considerations

> Review of the current market

> Logistics

> Review of leading companies

> Regulatory and QA issues

> ECG laboratories

> Imaging laboratories

> Future trends and challenges

The comprehensively-referenced report is published by Biopharm Knowledge Publishing, Part of the Technomark Group and is edited by Dr Graham Hughes, one of the leading experts on pharmaceutical outsourcing and one of the founders of Technomark. Contributors include:

Dr Graham Hughes

Richard Barrett

David J. Cocker

Eileen Daniel

Dr Colin Miller

Tim Stiles

This 250 page report provides a full picture of a fast-growing industry now worth more than $1 billion and vital to the success of drug development. It also gives a complete guide to managing the outsourcing and logistics process.

At just $2,100.00 for a 250 page report, Central and Core Laboratories is vital information for an affordable price. The report is required reading for executives in pharmaceutical companies, contract research organisations and laboratories, logistics and transportation companies as well as equipment suppliers and those investing in this expanding business area.

Format: PDF
Table of Contents
Table of Contents (PDF)
Price: $1,880.00 / €1,257.72

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions